Literature DB >> 26276770

B-acute lymphoblastic leukemia/lymphoblastic lymphoma.

Sanam Loghavi1, Jeffery L Kutok2, Jeffrey L Jorgensen3.   

Abstract

OBJECTIVES: This session of the 2013 Society of Hematopathology/European Association for Haematopathology Workshop was dedicated to B-acute lymphoblastic leukemia (B-ALL)/lymphoblastic lymphoma (LBL) with recurrent translocations and not otherwise specified.
METHODS: In this review, we summarize the cases discussed during the workshop, review the pertinent and most recent literature on the respective topics, and provide a few key points that may aid in the workup of patients with B-ALL/LBL.
RESULTS: Many of the submitted cases showed interesting diagnostic, immunophenotypic, or clinical aspects of B-ALL with BCR/ABL1, MLL-associated, and other recurrent chromosomal abnormalities. Several cases showed rare aberrancies such as coexistent IGH/BCL2 and MYC rearrangements and raised issues in classification. Other cases had unusual clinical presentations, including B-ALL with hypereosinophilia and therapy-related B-ALL. Several cases highlighted the role of flow cytometry immunophenotyping in distinguishing benign B-cell precursors from aberrant lymphoblasts, and other cases raised questions regarding the clinical importance of myeloperoxidase positivity in acute lymphoblastic leukemia.
CONCLUSIONS: The complexity and spectrum of cases presented in this review highlight the importance of clinicopathologic correlation and the value of ancillary studies in the classification and workup of patients with B-ALL/LBL. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  B-ALL; Cytogenetics; Flow cytometry immunophenotyping; Myeloid

Mesh:

Year:  2015        PMID: 26276770     DOI: 10.1309/AJCPAN7BH5DNYWZB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

Review 1.  Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Authors:  Christopher Wenzinger; Eli Williams; Alejandro A Gru
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

2.  BCR/ABL can promote CD19+ cell growth but not render them long-term stemness.

Authors:  Donghe Li; Xuemei Zhao; Ruihong Zhang; Bo Jiao; Ping Liu; Ruibao Ren
Journal:  Stem Cell Investig       Date:  2016-11-30

3.  Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.

Authors:  Laura Moench; Zohar Sachs; Garth Aasen; Michelle Dolan; Vanessa Dayton; Elizabeth L Courville
Journal:  Leuk Lymphoma       Date:  2016-02-18

4.  B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.

Authors:  Yiting Li; Gunjan Gupta; Ari Molofsky; Yi Xie; Nader Shihabi; Jane McCormick; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

5.  Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.

Authors:  Zheng Ge; Yan Gu; Lichan Xiao; Qi Han; Jianyong Li; Baoan Chen; James Yu; Yuka Imamura Kawasawa; Kimberly J Payne; Sinisa Dovat; Chunhua Song
Journal:  Oncotarget       Date:  2016-07-19

6.  Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia.

Authors:  Nawaf Alkhayat; Yasser Elborai; Omer Al Sharif; Mohammad Al Shahrani; Omar Alsuhaibani; Mohammed Awad; Hatem Elghezal; Inesse Ben-Abdallah Bouhajar; Mona Alfaraj; Eman Al Mussaed; Fahad Alabbas; Ghaleb Elyamany
Journal:  Clin Med Insights Oncol       Date:  2017-07-24

7.  CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome.

Authors:  Liting Chen; Bin Xu; Xiaolu Long; Jia Gu; Yaoyao Lou; Di Wang; Yang Cao; Na Wang; Chunrui Li; Gaoxiang Wang; Ying Wang; Li Zhu; Jin Wang; Haiyun An; Min Xiao; Yi Xiao; Jianfeng Zhou
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

8.  Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.

Authors:  Antonin Bouroumeau; Eleonore Kaphan; Clémentine Legrand; Tatiana Raskovalova; Gautier Szymanski; Claire Vettier; Christine Lefebvre; Marie-Christine Jacob; Anne McLeer; Michel Peuchmaur; Rémy Gressin; Hervé Sartelet
Journal:  J Med Case Rep       Date:  2020-07-27

9.  High-Grade B-Cell Neoplasm with Surface Light Chain Restriction and Tdt Coexpression Evolved in a MYC-Rearranged Diffuse Large B-Cell Lymphoma: A Dilemma in Classification.

Authors:  Dina Sameh Soliman; Ahmad Al-Sabbagh; Feryal Ibrahim; Ruba Y Taha; Zafar Nawaz; Sarah Elkourashy; Abdulrazzaq Haider; Susanna Akiki; Mohamed Yassin
Journal:  Case Rep Hematol       Date:  2017-08-13

10.  De Novo Precursor B-Lymphoblastic Leukemia/Lymphoma With Double-Hit Gene Rearrangements (MYC/BCL-2) Presented With Spinal Cord Compression and Acquired Factor XIII Deficiency.

Authors:  Dina Sameh Soliman; Ahmad Al-Sabbagh; Feryal Ibrahim; Shehab Fareed; Mohamed Talaat; Mohamed A Yassin
Journal:  J Hematol (Brossard)       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.